HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Alyasova Selected Research

N-nitrosoethylenethiourea

7/2014Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Alyasova Research Topics

Disease

1Renal Cell Carcinoma (Grawitz Tumor)
03/2016
1Vomiting
07/2014
1Nausea
07/2014
1Neoplasms (Cancer)
07/2014

Drug/Important Bio-Agent (IBA)

1Bevacizumab (Avastin)FDA Link
03/2016
1EverolimusFDA Link
03/2016
1CytokinesIBA
03/2016
1Sunitinib (Sutent)FDA Link
03/2016
1Sorafenib (BAY 43-9006)FDA Link
03/2016
1N-nitrosoethylenethioureaIBA
07/2014
1Ondansetron (Zofran)FDA LinkGeneric
07/2014
1netupitantIBA
07/2014
1Aprepitant (Emend)FDA Link
07/2014
1Palonosetron (Aloxi)FDA Link
07/2014
1Cisplatin (Platino)FDA LinkGeneric
07/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2014

Therapy/Procedure

2Drug Therapy (Chemotherapy)
03/2016 - 07/2014
1Therapeutics
03/2016